tiprankstipranks
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
US Market
NWBO
Northwest Biotherapeutics
RESEARCH TOOLSreports

Northwest Biotherapeutics (NWBO) Financial Statements

542 Followers

Northwest Biotherapeutics Financial Overview

Northwest Biotherapeutics's market cap is currently $336.89M. The company's EPS TTM is $-0.0295; its P/E ratio is -7.33; Northwest Biotherapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.38M$ 1.38M$ 1.93M$ 1.68M$ 1.00M
Gross Profit$ -959.00K$ 1.38M$ -25.80M$ 135.00K$ -19.30M
Operating Income$ -59.91M$ -66.51M$ -55.51M$ -67.18M$ -52.70M
EBITDA$ -57.58M$ -73.64M$ -55.34M$ -97.42M$ 184.72M
Net Income$ -61.48M$ -83.78M$ -62.60M$ -105.03M$ 179.13M
Balance Sheet
Cash & Short-Term Investments$ 3.04M$ 2.17M$ 2.13M$ 6.96M$ 15.17M
Total Assets$ 81.29M$ 26.73M$ 27.86M$ 31.32M$ 40.16M
Total Debt$ 64.83M$ 67.44M$ 45.56M$ 26.61M$ 38.26M
Net Debt$ 61.79M$ 65.27M$ 43.43M$ 19.64M$ 23.09M
Total Liabilities$ 128.86M$ 105.71M$ 74.92M$ 159.43M$ 164.15M
Stockholders' Equity$ -47.57M$ -78.98M$ -46.98M$ -128.10M$ -123.99M
Cash Flow
Free Cash Flow$ -46.27M$ -58.03M$ -57.07M$ -55.68M$ -44.31M
Operating Cash Flow$ -44.76M$ -57.02M$ -53.64M$ -52.77M$ -38.30M
Investing Cash Flow$ -1.81M$ -1.01M$ -3.44M$ -2.90M$ -6.01M
Financing Cash Flow$ 49.33M$ 56.78M$ 52.76M$ 41.97M$ 48.13M
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

Income Statement >

Northwest Biotherapeutics Debt to Assets

Balance Sheet >

Northwest Biotherapeutics Cash Flow

Cash Flow >

Northwest Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >